The Effectiveness of DBT-bGT Compared to Treatment as Usual for ADHD Adults

The following is a summary of the “Dialectical behavioral therapy-based group treatment versus treatment as usual for adults with attention-deficit hyperactivity disorder: a multicenter randomized controlled trial” published in the November 2022 issue of Psychiatry by Halmøy et al. Studies on structured skills training groups have revealed favorable, although still unclear, effects on core symptoms…

Read More

Behavioral Telehealth Loses Momentum Without a Regulatory Boost

Controlled substances became a little less controlled during the pandemic. That benefited both patients (for their health) and telehealth startups (to make money). Some potentially addictive medications — like buprenorphine and Adderall — are now far more available online to patients because of regulatory changes.

Read More

Inflow, a platform for managing ADHD through cognitive behavioral therapy, raises $11M

Inflow, a company developing a platform to manage ADHD using cognitive behavioural therapy (CBT) techniques, has raised $11 million in a Series A round of funding. ADHD, or “attention deficit hyperactivity disorder,” is a condition impacting as much as 10% of the global population. Symptoms vary, but typically involve inattention, hyperactivity, anxiety and impulsivity.

Read More

fMRI Neurofeedback Ineffective in Improving Pediatric ADHD Symptoms

Functional MRI neurofeedback (fMRI-NF) may be ineffective in improving clinical symptoms or cognition in boys with attention-deficit/hyperactivity disorder (ADHD), according to a recent double-blind, sham-controlled randomized controlled trial. Researchers published their results in The American Journal of Psychiatry.

Read More

ADHD Drug Shortages Spread to Generic Ritalin

Shortages of ADHD medications that started this summer with Adderall have widened to now include another major category of stimulants. For the past two months, patients have had a hard time finding methylphenidate drugs, a class that includes Novartis AG’s Ritalin and Johnson & Johnson’s Concerta. A drug manufacturer and a major pharmacy told Bloomberg…

Read More

Work-related Stress and Mental Illness in Adults with ADHD

The following is a summary of the “Stress and work-related mental illness among working adults with ADHD: a qualitative study” published in the November 2022 issue of Psychiatry by Oscarsson et al. Few studies have examined the experience of working as an adult with attention deficit hyperactivity disorder(ADHD), despite the fact that many adults with…

Read More

2 Things It’s Best Not to Say to Children With ADHD

KEY POINTS: Kids with ADHD may seem unruly at times, but the behavior is not necessarily intentional, nor simple for them to control. How adults respond to kids’ ADHD can shape their self-view and dictate whether conduct disturbances develop. Telling an ADHD child to “behave” or that they need “to just focus” doesn’t consider their…

Read More